At thirty-four weeks pregnant, you're getting closer to the big day and there’s plenty of exciting things in store. One ...
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369] Draft guidance Technology appraisal guidance 2 April ...